Brief: Wockhardt Says Has Not Finalised Commercial Agreements For COVID-19 Vaccine
31/05/2021 07:16
May 31 (Reuters) - Wockhardt Ltd WCKH.NS :
* IN PROCESS OF NEGOTIATING COVID-19 VACCINE MANUFACTURING
OPTIONS
WITH GLOBAL DEVELOPERS AS PART OF ITS NORMAL PHARMA BUSINESS
* CO HAS NOT FINALISED COMMERCIAL AGREEMENTS WITH PARTY
Source text: (https://bit.ly/3wNwJfA)
Further company coverage: WCKH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter